— Know what they know.
Not Investment Advice

000908.SZ SHZ

Hunan Jingfeng Pharmaceutical Co.,Ltd.
1W: -1.8% 1M: -7.1% 3M: -4.2% YTD: -10.2% 1Y: -0.2% 3Y: +133.1% 5Y: +18.1%
¥5.99 ($0.89)
+0.04 (+0.67%)
 
SHZ · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 35 · ¥10.5B mcap · 1.67B float · 1.51% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap¥10.5B ($1.6B)
52W Range4.58-9.48
Volume10,870,900
Avg Volume25,222,716
Beta-0.50
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOXiang Wu Ye
Employees463
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date1999-02-03
Shuangchuang Building
Changde, HU 415001
CN
86 21 6686 1001
About Hunan Jingfeng Pharmaceutical Co.,Ltd.

Hunan Jingfeng Pharmaceutical Co.,Ltd., established in 2003 and headquartered in Shanghai, China, operates as a manufacturer and supplier of various pharmaceutical products, including chemical compounds and biological agents, within the Chinese market. A prominent offering from the company is its sodium hyaluronate injection, which finds extensive application in both orthopedic and surgical fields. Beyond this, their product range encompasses ophthalmology solutions and Active Pharmaceutical Ingredients (APIs). The firm also dedicates resources to the research and development of medications for anti-tumor, cancer, and cardiovascular conditions, alongside providing a selection of skincare products.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms